These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18234009)

  • 1. Sodium channel blockers enhance the temporal QT interval variability in the right precordial leads in Brugada syndrome.
    Kanemori T; Shimizu H; Oka K; Furukawa Y; Hiromoto K; Mine T; Masuyama T; Ohyanagi M
    Ann Noninvasive Electrocardiol; 2008 Jan; 13(1):74-80. PubMed ID: 18234009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different effect of the pure Na+ channel-blocker pilsicainide on the ST-segment response in the right precordial leads in patients with normal left ventricular function.
    Ueyama T; Shimizu A; Yamagata T; Esato M; Ohmura M; Yoshiga Y; Kanemoto M; Kametani R; Sawa A; Suzuki S; Sugi N; Matsuzaki M
    Circ J; 2007 Jan; 71(1):57-62. PubMed ID: 17186979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
    Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
    G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sodium-channel blockade on early repolarization in inferior/lateral leads in patients with idiopathic ventricular fibrillation and Brugada syndrome.
    Kawata H; Noda T; Yamada Y; Okamura H; Satomi K; Aiba T; Takaki H; Aihara N; Isobe M; Kamakura S; Shimizu W
    Heart Rhythm; 2012 Jan; 9(1):77-83. PubMed ID: 21855521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right ventricular dysfunction in patients with Brugada-like electrocardiography: a two dimensional strain imaging study.
    Murata K; Ueyama T; Tanaka T; Nose Y; Wada Y; Matsuzaki M
    Cardiovasc Ultrasound; 2011 Nov; 9():30. PubMed ID: 22085903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome.
    Morita H; Morita ST; Nagase S; Banba K; Nishii N; Tani Y; Watanabe A; Nakamura K; Kusano KF; Emori T; Matsubara H; Hina K; Kita T; Ohe T
    J Am Coll Cardiol; 2003 Nov; 42(9):1624-31. PubMed ID: 14607450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and initial characteristics of pilsicainide-induced ventricular arrhythmias in patients with Brugada syndrome.
    Chinushi M; Komura S; Izumi D; Furushima H; Tanabe Y; Washizuka T; Aizawa Y
    Pacing Clin Electrophysiol; 2007 May; 30(5):662-71. PubMed ID: 17461877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome.
    Tada T; Kusano KF; Nagase S; Banba K; Miura D; Nishii N; Watanabe A; Nakamura K; Morita H; Ohe T
    J Cardiovasc Electrophysiol; 2008 Jan; 19(1):56-61. PubMed ID: 17916151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilsicainide Administration Unmasks a Phenotype of Brugada Syndrome in a Patient with Overlap Syndrome due to the E1784K SCN5A Mutation.
    Hasebe H; Yokoya T; Murakoshi N; Kurebayashi N
    Intern Med; 2020 Jan; 59(1):83-87. PubMed ID: 31484910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome.
    Ueoka A; Morita H; Watanabe A; Morimoto Y; Kawada S; Tachibana M; Miyamoto M; Nakagawa K; Nishii N; Ito H
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29748178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should all individuals with a nondiagnostic Brugada-electrocardiogram undergo sodium-channel blocker test?
    Zorzi A; Migliore F; Marras E; Marinelli A; Baritussio A; Allocca G; Leoni L; Perazzolo Marra M; Basso C; Buja G; Thiene G; Iliceto S; Delise P; Corrado D
    Heart Rhythm; 2012 Jun; 9(6):909-16. PubMed ID: 22334153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome.
    Shimizu W; Antzelevitch C; Suyama K; Kurita T; Taguchi A; Aihara N; Takaki H; Sunagawa K; Kamakura S
    J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1320-9. PubMed ID: 11196553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QT-interval prolongation in right precordial leads: an additional electrocardiographic hallmark of Brugada syndrome.
    Pitzalis MV; Anaclerio M; Iacoviello M; Forleo C; Guida P; Troccoli R; Massari F; Mastropasqua F; Sorrentino S; Manghisi A; Rizzon P
    J Am Coll Cardiol; 2003 Nov; 42(9):1632-7. PubMed ID: 14607451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longer repolarization in the epicardium at the right ventricular outflow tract causes type 1 electrocardiogram in patients with Brugada syndrome.
    Nagase S; Kusano KF; Morita H; Nishii N; Banba K; Watanabe A; Hiramatsu S; Nakamura K; Sakuragi S; Ohe T
    J Am Coll Cardiol; 2008 Mar; 51(12):1154-61. PubMed ID: 18355652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conduction delay in right ventricle as a marker for identifying high-risk patients with Brugada syndrome.
    Doi A; Takagi M; Maeda K; Tatsumi H; Shimeno K; Yoshiyama M
    J Cardiovasc Electrophysiol; 2010 Jun; 21(6):688-96. PubMed ID: 20050961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: insight into the mechanism of Brugada syndrome.
    Fujiki A; Usui M; Nagasawa H; Mizumaki K; Hayashi H; Inoue H
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):214-8. PubMed ID: 10090224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right bundle branch block and coved-type ST-segment elevation mimicked by acute cholecystitis.
    Furuhashi M; Uno K; Satoh S; Hoshikawa K; Sakai E; Tsuchihashi K; Shimamoto K
    Circ J; 2003 Sep; 67(9):802-4. PubMed ID: 12939560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single oral flecainide dose to unmask type 1 Brugada syndrome electrocardiographic pattern.
    Dubner S; Azocar D; Gallino S; Cerantonio AR; Muryan S; Medrano J; Bruno C
    Ann Noninvasive Electrocardiol; 2013 May; 18(3):256-61. PubMed ID: 23714084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrimination of Brugada syndrome patients from individuals with the saddle-back type ST-segment elevation using a marker of the standard 12-lead electrocardiography.
    Nakazawa K; Sakurai T; Kishi R; Takagi A; Osada K; Ryu S; Fujita S; Matsuda H; Ishikawa Y; Miyake F
    Circ J; 2007 Apr; 71(4):546-9. PubMed ID: 17384457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of conduction delay in the right ventricular outflow tract between Brugada syndrome and right ventricular cardiomyopathy: investigation of signal average ECG in the precordial leads.
    Furushima H; Chinushi M; Okamura K; Iijima K; Komura S; Tanabe Y; Okada S; Izumi D; Aizawa Y
    Europace; 2007 Oct; 9(10):951-6. PubMed ID: 17636305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.